These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 12355579)

  • 1. Disposition of acamprosate in the rat: influence of probenecid.
    Zornoza T; Guerri C; Polache A; Granero L
    Biopharm Drug Dispos; 2002 Oct; 23(7):283-91. PubMed ID: 12355579
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence of a flip-flop phenomenon in acamprosate pharmacokinetics: an in vivo study in rats.
    Zornoza T; Cano-Cebrián MJ; Hipólito L; Granero L; Polache A
    Biopharm Drug Dispos; 2006 Oct; 27(7):305-11. PubMed ID: 16799924
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Competitive inhibition of renal tubular secretion of ciprofloxacin and metabolite by probenecid.
    Landersdorfer CB; Kirkpatrick CM; Kinzig M; Bulitta JB; Holzgrabe U; Jaehde U; Reiter A; Naber KG; Rodamer M; Sörgel F
    Br J Clin Pharmacol; 2010 Feb; 69(2):167-78. PubMed ID: 20233180
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical pharmacokinetics of acamprosate.
    Saivin S; Hulot T; Chabac S; Potgieter A; Durbin P; Houin G
    Clin Pharmacokinet; 1998 Nov; 35(5):331-45. PubMed ID: 9839087
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics and the effect of probenecid on the renal excretion mechanism of diprophylline.
    Nadai M; Apichartpichean R; Hasegawa T; Nabeshima T
    J Pharm Sci; 1992 Oct; 81(10):1024-7. PubMed ID: 1432614
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A microdialysis study of extracellular levels of acamprosate and naltrexone in the rat brain following acute and repeated administration.
    Burattini C; McGeehan AJ; Griffin WC; Gass JT; Kinder JR; Janak PH; Olive MF
    Addict Biol; 2008 Mar; 13(1):70-9. PubMed ID: 18269381
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A nonprimate animal model applicable to zidovudine pharmacokinetics in humans: inhibition of glucuronidation and renal excretion of zidovudine by probenecid in rats.
    Mays DC; Dixon KF; Balboa A; Pawluk LJ; Bauer MR; Nawoot S; Gerber N
    J Pharmacol Exp Ther; 1991 Dec; 259(3):1261-70. PubMed ID: 1762074
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of renal tubular transport of methotrexate by probenecid.
    Bourke RS; Chheda G; Bremer A; Watanabe O; Tower DB
    Cancer Res; 1975 Jan; 35(1):110-6. PubMed ID: 1109785
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kinetic study of acamprosate absorption in rat small intestine.
    Más-Serrano P; Granero L; Martín-Algarra RV; Guerri C; Polache A
    Alcohol Alcohol; 2000; 35(4):324-30. PubMed ID: 10905995
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renal responses and pharmacokinetics of piretanide in humans: effect of route of administration, state of hydration and probenecid pretreatment.
    Noormohamed FH; McNabb WR; Dixey JJ; Lant AF
    J Pharmacol Exp Ther; 1990 Sep; 254(3):992-9. PubMed ID: 2395126
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differences in the pharmacokinetics of 4-amino-3-chlorophenyl hydrogen sulfate, a metabolite of resatorvid, in rats and dogs.
    Jinno F; Takeuchi T; Tagawa Y; Kondo T; Itoh T; Asahi S
    Drug Metab Dispos; 2012 Apr; 40(4):648-54. PubMed ID: 22203697
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renal tubular secretion and reabsorption as factors in ochratoxicosis: effects of probenecid on nephrotoxicity.
    Stein AF; Phillips TD; Kubena LF; Harvey RB
    J Toxicol Environ Health; 1985; 16(3-4):593-605. PubMed ID: 4087321
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Studies on the renal excretion mechanisms of cefadroxil.
    Granero L; Gimeno MJ; Torres-Molina F; Chesa-Jiménez J; Peris JE
    Drug Metab Dispos; 1994; 22(3):447-50. PubMed ID: 8070323
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Absorption, disposition kinetics, and metabolic pathways of cyclohexene oxide in the male Fischer 344 rat and female B6C3F1 mouse.
    Sauer JM; Bao J; Smith RL; McClure TD; Mayersohn M; Pillai U; Cunningham ML; Sipes IG
    Drug Metab Dispos; 1997 Mar; 25(3):371-8. PubMed ID: 9172957
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renal handling of zomepirac sodium (McN-2783-21-98) in the rat.
    O'Neill PJ; Yorgey KA; Migdalof BH; Gussin RZ
    J Pharmacol Exp Ther; 1979 Jun; 209(3):366-70. PubMed ID: 35605
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Probenecid protects against In vivo acetaminophen-induced nephrotoxicity in male Wistar rats.
    Trumper L; Monasterolo LA; Elías MM
    J Pharmacol Exp Ther; 1998 Feb; 284(2):606-10. PubMed ID: 9454804
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of probenecid on furosemide kinetics and natriuresis in man.
    Honari J; Blair AD; Cutler RE
    Clin Pharmacol Ther; 1977 Oct; 22(4):395-401. PubMed ID: 902452
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disposition and pharmacokinetics of the antimigraine drug, rizatriptan, in humans.
    Vyas KP; Halpin RA; Geer LA; Ellis JD; Liu L; Cheng H; Chavez-Eng C; Matuszewski BK; Varga SL; Guiblin AR; Rogers JD
    Drug Metab Dispos; 2000 Jan; 28(1):89-95. PubMed ID: 10611145
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of 5-fluorouracil in rats with diabetes mellitus induced by streptozotocin.
    Choi YH; Lee AK; Bae SK; Kim SO; Lee MG
    Biopharm Drug Dispos; 2005 Apr; 26(3):93-8. PubMed ID: 15674819
    [TBL] [Abstract][Full Text] [Related]  

  • 20. No effect of probenecid on the renal excretion mechanism of a new carbapenem, DA-1131, in dogs.
    Kim SH; Kim WB; Lee MG
    Res Commun Mol Pathol Pharmacol; 1998 Jul; 101(1):85-92. PubMed ID: 9755846
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.